- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$106 MnMarket Estimate, 2026
$115.43 MnMarket Forecast, 2034
$228 MnCAGR, 2026–2034
8.9%North America Gamma Knife Market Size, Growth, Trends & Forecast (2026–2034)
The North America Gamma Knife Market size was calculated to be USD 106 million in 2025, is estimated to reach USD 115.43 million in 2026, and is projected to expand to USD 228 million by 2034, registering a compound annual growth rate (CAGR) of 8.90% during the forecast period from 2026 to 2034. Driven by the escalating incidence of chronic illnesses like cancer and neurological disorders, rising demand for non-invasive stereotactic radiosurgery, and advanced medical infrastructure, the market continues to record a dominant regional share globally.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 106 Million
- 2026 Current Valuation: USD 115.43 Million
- 2034 Forecast Valuation: USD 228 Million
- Compound Annual Growth Rate (CAGR): 8.90% (2026–2034)
- Leading Country Markets: United States (accounting for ~20% of the regional market with dominant tier-1 adoption) and Canada
- Key Growth Hubs: U.S. and Canadian metropolitan medical research and oncology centers
Core Market Drivers
- Rising Chronic & Neurological Conditions: Increasing prevalence of brain tumors, metastases, meningiomas, and other intracranial disorders among the aging demographic.
- Demand for Non-Invasive Technologies: Preference for cutting-edge, precision-guided radiosurgery that minimizes post-surgical complications and tissue damage in the head, neck, and spine.
- Software & Digital Integration: Systematic utilization of integrated imaging and AI-powered software for continuous, real-time dose delivery tracking.
Primary Market Restraints & Challenges
- High Equipment & Operating Costs: Substantial capital investments required for purchasing and maintaining advanced Gamma Knife infrastructure.
- Regulatory & Staffing Constraints: Lengthy approval timelines for new device rollouts compounded by a shortage of specialized clinical and medical professionals.
Market Segmentation: Largest and Fastest-Growing Segments
| Segment Category | Largest Segment | Fastest-Growing Segment |
|---|---|---|
| By Disease Indication | Brain Metastasis & Cancer | Trigeminal Neuralgia & AVM |
| By Country | United States | Canada (Supported by government health plans) |
Major Industry Players Profiled
Key market participants shaping the North America Gamma Knife landscape include Varian Medical Systems, Elekta AB, Cyber Medical Corporation Ltd., Huiheng Medical Inc., Masep Infini North America, Inc., Hokai, Nordion Inc., ET Medical Group, and American Shared Hospital Services, among others.
North America Gamma Knife Market Size
The North America gamma knife market had a valuation of USD 106 million in 2025, is expected to be USD 115.43 million in 2026, and is forecast to reach USD 228 million by 2034, with a CAGR of 8.90% from 2026 to 2034.
MARKET DRIVERS
Rising Chronic Diseases, Demand for Non-Invasive Treatments
The North America Gamma Knife market is expected to be majorly driven by factors such as the increasing incidence of chronic diseases, such as cancer and neurological conditions, across the region. Also, the growing demand for edge-cutting technologies to operateon tumors detected in the spine, neck, and head is projected to fuel the market growth.
As per WHO's data, Europe accounts for only one-eighth of the worldwide population yet accounts for almost one-quarter of all cancer cases, with approximately 3.7 million new patients each year. Most cancer deaths are caused by lung, breast, stomach, liver, colon, and colon cancer. Cancer is becoming more common as a result of lifestyle changes.
The growing geriatric cancer population requires the development of non-invasive, accurate treatments with fewer adverse effects. According to the Neurological Alliance, one out of every six people has a neurological problem. As a result, a gamma knife can be used in meningioma surgery, stereotactic radiosurgery, and the treatment of numerous neurological disorders.
The rising methodical use of integrated imaging software to keep a constant track of dose delivery is expected to boost the market growth.
The growing adoption of radiation devices and innovations to ensure minimal invasion and reduced postsurgical complications in surgery is estimated to support the market growth.
Key market players focus on introducing innovations to provide advanced patient care, which is expected to uplift the market growth. In addition, key market strategies such as partnerships, mergers, and acquisitions are most likely to expand the European regional market growth.
In addition, Brainlab, a digital medical technology company, has announced the acquisition of Mint Medical GmbH. This medical technology company specializes in image reading and reporting software for clinical routine and research. Therefore, this acquisition is expected to help accelerate the automation of radiology reports through AI anatomical mapping and the creation of holistic data.
MARKET RESTRAINTS
High Equipment Costs and Delayed Approvals
The high cost of the equipment is a major concern impeding the market growth. In addition, the lack of medical professionals long approval time associated with the new gamma knife system launch is expected to hinder the market growth.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| Segments Covered | By Disease Indication and Region. |
| Various Analyses Covered | Global, Regional and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Countries Covered | United States, Canada, Mexico, Rest of North America |
| Market Leaders Profiled | Varian Medical Systems, Elekta AB, Cyber Medical Corporation Ltd., Huiheng Medical Inc., Masep Infini North America, Inc., Hokai, Nordion Inc., ET Medical Group, and American Shared Hospital Services, among others. |
REGIONAL ANALYSIS
Geographically, the North American region holds the most significant share of the gamma knife market, and it is predicted to register a predominant share during the forecast period.
The U.S Gamma Knife Market is likely to account for 20% of the gamma knife market in North America. During the forecast period, the demand for gamma knives will increase, with tier-1 firms accounting for 60-65 percent of the gamma knife market.
The Canadian Gamma Knife Market is anticipated to witness a significant share due to the growing population, government insurance plans for radiotherapy, and supportive government policies. In addition, factors such as the high prevalence of cancer, neurological disorders, technological advancements, and growing healthcare expenditure propel market growth.
The proliferation of brain tumors, the growing usage of accurate and efficient integrated imaging software, and the improvement in the healthcare sector contribute to market growth.
KEY MARKET PLAYERS
Companies playing a dominant role in the North America Gamma Knife Market profiled in this report are Varian Medical Systems, Elekta AB, Cyber Medical Corporation Ltd., Huiheng Medical Inc., Masep Infini North America, Inc., Hokai, Nordion Inc., ET Medical Group, and American Shared Hospital Services, among others.
MARKET SEGMENTATION
This research report on the North America Gamma Knife Market has been segmented and sub-segmented into the following categories:
By Disease Indication
- Brain Metastasis
- Cancer
- Trigeminal Neuralgia
- AVM
- Others
By Country:
- U.S
- Canada
- Rest of North America